Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors, modulators |
Mechanism CLK inhibitors(Clk dual-specificity kinases inhibitors), DYRK inhibitors(DYRK kinase inhibitors), Wnt signalling pathway modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Leukemia | Preclinical | Australia | 30 Apr 2025 | |
Solid tumor | Preclinical | Australia | 30 Apr 2025 | |
Mantle-Cell Lymphoma | Preclinical | United States | 13 Nov 2019 |